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Aim. The aim of this study was to identify the presence of H. pylori in biopsy specimens from symptomatic patients by PCR. In
addition, the rate of cagA, vacA, iceA1, and iceA2 virulence genes was determined. Materials and Methods. One hundred antral
gastric biopsy specimens were collected during endoscopy from patients suffering from gastroduodenal symptoms. The samples
were collected by the gastroenterologists in their own clinics in Ramallah, Palestine. DNA was extracted from the biopsies and
subsequently used for PCR identification ofH. pylori and the virulence genes using specific primers. Results. The rate of positiveH.
pylori in the collected biopsies was 44%. The rates of the virulence genes in this sample: cagA, vacA, iceA1, and iceA2 were 65.9%,
40.9%, 63.6%, and 84.1%, respectively. Conclusion. The iceA2 gene was the most frequent in this study. Much research is necessary
to determine the presence of an association of this gene with gastric pathology. Variation in the rates of the iceA gene in different
countries is a strong indication of its geographical distribution. This study would provide important information regarding the
prevalence of virulence genes (vacA, cagA, iceA1, and iceA2) in H. pylori strains in the sample tested in this country.
1. Introduction
Helicobacter pylori is a microaerophilic, spiral shaped Gram-
negative bacterium that colonizes the human stomach. It has
been linked to chronic active gastritis, peptic ulcers disease,
gastric cancer, and mucosa-associated lymphoid tissue lym-
phoma [1, 2]. H. pylori has been classified as a definite class I
carcinogen by the World Health Organization [3]. Although
the prevalence ofH. pylori infectionmay exceed 70% in some
developing countries [4, 5], only a small percentage of the
population develop severe disease. This can be attributed
to the involvement of specific factors that contribute to
the pathogenicity of this organism. The cytotoxin-associated
gene (cagA), a marker for cag pathogenicity island, is associ-
ated with severe clinical diseases as seen in peptic ulcer dis-
ease and gastric adenocarcinoma [1]. The vacuolating cyto-
toxin (vacA) gene encodes for the vacuolating cytotoxin, the
pore forming toxin which causes progressive vacuolation and
injury to gastric epithelium [6, 7]. The induced by contact
with epithelium (iceA) A gene has been considered as the
marker for peptic ulcer disease.
The aims of this study were to identify H. pylori directly
from biopsy specimen collected from symptomatic patients
using primers to amplify theureA and glmM (ureC) genes and
to determine the rate of virulence genes, cagA, vacA, iceA1 and
iceA2, in the biopsy samples by PCR.
2. Methods
2.1. Specimen Collection and Processing. Antral gastric biopsy
specimens were collected during upper endoscopy from 100
patients suffering from gastroduodenal symptoms. Patient’s
consent to participate in this study was obtained prior
to enrollment. The samples were collected by gastroen-
terologists between January and August 2012. DNA was
extracted from the biopsies by the QIAamp DNA Mini Kit
(Qiagen, Valencia, CA, USA) following the manufacturer’s
instructions. Extracted DNA was used for subsequent PCR
experiments.
2.2. Polymerase Chain Reaction. Amplification was conduc-
ted in a total volume of 25 𝜇L.The reactionmixture contained
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Table 1: Primers used for the amplification of H. pylori genes.
Primer 5󸀠-3󸀠 sequence Product size (bp) Annealing (∘C)
CagA-F AATACACCAACGCCTCCAAG 400 55
CagA-R TTGTTGGCGCTTGCTCTC
VacA-3.AS GCCGATATGCAAATGAGCCGC 678 66
VacA-1.SE CAATCGTGTGGGTTCTGGAGC
IceA1-F CGTTGGGTAAGCGTTACAGAATTT 558 56
IceA1-R TCATTGTATATCCTATCATTACAAG
IceA2-F GTTGTCGTTGTTTTAATGAA 120 50
IceA2-R GTCTTAAACCCCACGATTAAA
HPU1 GCCAATGGTAAATTAGTT 411 45
HPU2 CTCCTTAATTGTTTTTAC
GlmM-F AAGCTTTTAGGGGTGTTAGGGGTTT 294 55
GlmM-R AAGCTTACTTTCTAACACTAACGC
Table 2: Genes used in the PCR identification of H. pylori and virulence genes determination.
Genes
cagA vacA iceA1 iceA2 ureA 𝑔𝑙𝑚𝑀 (𝑢𝑟𝑒𝐶)
Positive 29 (65.9%) 19 (43.2%) 28 (63.6%) 37 (84.1%) 41 (93.2%) 43 (98%)
Negative 15 (34.1%) 25 (56.8%) 16 (36.4%) 7 (15.9%) 3 (6.8%) 1 (2%)
Total 44 (100%) 44 (100%) 44 (100%) 44 (100%) 44 (100%) 44 (100%)
12.5 uL, 2X ready PCRmix (Thermo Scientific) and consisted
of 1.25U Taq-Pol, 75mM Tris-HCL (pH 8.8), 1.5mMMgCl
2
,
and 0.2mM of each dNTP. The reaction mixture contained
12.5 uL master mix, 1.0 uM of each forward and reverse
primers (Table 1), 1 ug DNA template, and 8.5 uL RNase free
water to a total volume of 25 uL.The amplificationwas carried
out in a C-1000 thermal cycler (Bio-Rad, USA) according
to the following program: an initial denaturation step at
95∘C for 10min, followed by 35 cycles of denaturation at
95∘C for 30 s, annealing, primer specific shown in Table 1 for
1min, and a final extension step at 72∘C for 5min. Amplified
PCR products were resolved by agarose gel electrophoresis
(5 V/60min) using 1,5% agarose in Tris Acetate-EDTA (TAE)
buffer containing 0.5 ug/mL of ethidium bromide. Molecular
size ladder of 100 bp (Fermentans, Germany) was used to
determine the size of the bands. The gel was viewed and
photographed on a Gel-Doc System (Bio-Rad, USA). The
primers used for the amplifications were obtained from
Invitrogen (Rhenium, Jerusalem), shown in Table 1.
3. Results
Antral biopsies were collected from 100 patients. Molecular
identification of H. pylori was performed on all biopsies
by PCR using primers (HPU1, HPU2) to amplify a 411 bp
product for the ureA gene and primers (GlmM-F, GlmM-
R) to amplify a 294 bp product for the glmM (ureC) gene
(Table 2). The rate of positive H. pylori in the biopsies tested
was 44% (44/100). The rate of virulence genes cagA, vacA,
iceA1, and iceA2 in the positive biopsies for H. pylori is
summarized in Table 2.
4. Discussion
The glmM gene is highly conserved and has been used to
identify H. pylori in gastric biopsies. Although it has been
reported that the sensitivity and specificity of ureA is more
than 90% [8], the glmM gene has better sensitivity than the
ureA gene [9]. One of the advantages of using the glmM gene
to identify H. pylori directly in gastric biopsies is its high
degree of sensitivity and specificity, since it has a detec-
tion rate of 10 to 100 H. pylori cells which is better than
histopathology [10]. Our findings revealed a rate of positive
H. pylori in the tested biopsies of 44% based on direct
molecular detection by PCR using the ureA and the glmM
genes. To improve DNA extraction from the biopsies and to
eliminate PCR inhibitors, a special extraction kit fromQiagen
was used [11].
The induced by contact with epithelium (iceA) gene has
two allelic forms, iceA1 and iceA2.The iceA1 gene is expressed
by H. pylori upon contact with the gastric epithelial cells
[12]. Although iceA gene has not been associated with gastric
cancer, there is an unresolved controversy for the role of this
gene in gastric pathology. Reports have associated the iceA1
allele in peptic ulcer [12, 13] while others did not find any role
for this allele in gastroduodenal disease [13]. The iceA2 allele
has been inversely associated with peptic ulcer [14].
There are significant variations reported regarding the
prevalence of if iceA1 and iceA2 alleles. The iceA1 has been
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reported to be the prevalent allele in some studies [12] while
iceA2 the prevalent allele in others [15].
The iceA2 gene was the most frequent in this study
(84.4%). A Brazilian study reported a rate of 90.1% for the
iceA2 allele [16]. Contrary to that, a Mexican study reported
a rate of 9% for the iceA2 allele, while 72% carried both genes
iceA1 and iceA2 [17]. In East Asia, the iceA1 genotype has been
reported to be the predominant (76%) while in Portugal and
Colombia icaA2 is predominant [18]. The rate of the iceA1
gene in this study was 62.2% and 53.3% of the samples carried
both genes iceA1 and iceA2. This variation in rates for the
iceA gene in different countries is a strong indication of its
geographical distribution.
The cagA results in our study of 65.9% are similar to those
obtained in Tunisia of 61.6% [19]. They are higher than those
obtained in Pakistan (56%), but lower than rates reported in
Iran (76%), Iraq (71%) [19], India, and Bangladesh of 70%
[20].The cagA positive strains in the Mexican study was 86%
[17]. In Japan, the rate of cagA is very high (90%) [19], which
is correlated with the commonly encountered gastric cancer
in that country.
The cagA and the vacA genes are major virulence factors
in H. pylori responsible for the gastric pathology. The poly-
morphic nature of the vacA gene, due to allelic variations
in the signal and middle regions of the gene, has not
been addressed in this study. The rate of the vacA gene in
the sample tested was 40.9%. vacA negativeH. pylori has been
detected in biopsy specimens in Sweden [21]. Our find-
ings revealed the presence of 7 combinations of genotypes
based on the cag/vac genes as shown in Table 2. In one
biopsy specimen, cagA negative/vacA negative genotype was
encountered. Although the other virulence genes were tested
(iceA1 and iceA2), the identity of this isolate as H. pylori was
confirmed by repeating the amplification with ureA primers.
In conclusion, this study would provide important infor-
mation regarding the rate of virulence factors in this country.
Determination of virulence genes may provide information
regarding the risk of clinical outcomes in symptomatic
patients.
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